The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
about
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like MechanismDopamine release in the basal gangliaParkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer modelRiluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studySystematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activitiesReview: Multiple system atrophy: emerging targets for interventional therapiesGlia and alpha-synuclein in neurodegeneration: A complex interactionExploring the accessible conformations of N-terminal acetylated α-synucleinA progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") miceWhat macromolecular crowding can do to a proteinMitochondrial dysfunction and oxidative stress in Parkinson's diseaseStructures of segments of α-synuclein fused to maltose-binding protein suggest intermediate states during amyloid formationMicroRNAs in NeurotoxicityC. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during agingRepression of alpha-synuclein expression and toxicity by microRNA-7.Role of Rab GTPases in membrane traffic and cell physiologyAstrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.Genetic mouse models of parkinsonism: strengths and limitations.Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathyModulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze?Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Protein disorder in the human diseasome: unfoldomics of human genetic diseases.Unfoldomics of human diseases: linking protein intrinsic disorder with diseasesActivation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease.Autonomic dysfunction and plasticity in micturition reflexes in human α-synuclein mice.MicroRNA-7a regulates pancreatic β cell function.The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosisStructure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicityLysosomes and α-synuclein form a dangerous duet leading to neuronal cell death.Stable alpha-synuclein oligomers strongly inhibit chaperone activity of the Hsp70 system by weak interactions with J-domain co-chaperonesRegion specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathyBiochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expressionMechanism of copper(II)-induced misfolding of Parkinson's disease protein.Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression.Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice.Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
P2860
Q21284823-D5CE1325-8A87-44C7-B192-148BF748A2F5Q22251247-BF7EF520-A456-48E6-8FD2-351D91C829E2Q24305472-0371AFF0-ED4A-4EAD-AA7A-59B4128499E3Q24655620-A90F202B-BBF7-43EC-9411-011721A0494FQ26269871-F8C5E4A4-90D2-40FD-8A26-2696B09C6C55Q26770919-85CAFC3E-C4A7-4119-9FB1-DDB2D9A65564Q26851153-6F448419-9396-42C4-BD0A-D344AF846CC8Q26852660-122D236A-2C5F-4859-943E-016F4A96B1ECQ26859072-D142AC83-3ED1-4525-8481-A8D29D6936ADQ27012942-8E1E676E-8306-4705-9272-F9CF0BFE1990Q27014051-1E793D9A-4016-4749-93A7-285085A02699Q27667412-5FC41776-D1E7-4B38-8DAF-C7F0156CF4FDQ28382954-0AB1B3AE-7542-4CE0-B2CB-E67AE6420176Q28472271-2AB92B8C-CBFA-4F0B-9A4B-E352122A4D6AQ29542272-264E5E50-5596-479E-8D1B-B5F5CAD7F957Q29616548-42F69470-B309-4AB1-A6AA-39A809B06DA0Q30494594-740312EC-BF6F-4797-B627-279283933307Q30537732-5B2E2605-788A-4E90-9C53-272B2D55D2E9Q30662442-F428399B-309D-4B02-A625-BB87EC0C5502Q33392127-652B338E-F95E-4A04-8FDB-73FEAD91CC06Q33394700-D27BCA1B-C3AF-499A-BCE5-8D124A96F114Q33470625-56631711-7CD3-4936-B269-7D0827D8710BQ33481211-3A449F39-AE2C-45BB-BC9F-35C0806A6C53Q33481254-6EC66101-BF22-466E-A64B-EF6CD0FC0955Q33517934-6F2B6A47-C940-4900-A017-9396CF8F1F08Q33640037-04D01B15-69F5-4216-898F-E02700D3D501Q33685948-DABCA10E-ECB1-444D-8327-3F1E4E465EE4Q33938412-44788679-19AC-4592-A6BD-13494658D5D5Q34003885-F1812CC4-6291-4F80-BE98-F9C85EE9E6F9Q34043163-AA0E7A5B-ECEE-429D-9A46-E0EE7B366912Q34352138-0CF4A124-0D27-4C75-9A82-7A23BABBBA03Q34380871-EB897EE4-8D5E-4CFD-8324-0A4D9245AC3EQ34544824-8684894F-2A6B-4227-9ADE-7F3DB0789692Q34769745-3399221F-E1B7-411B-81E8-F22F46E514CBQ34991077-23F8839F-54D5-4A9B-97E7-FE218789F3B2Q35551295-47F68BED-8FFF-4FF0-856A-54A32B721367Q35791524-22F470D2-CD96-4790-829B-A490BE7C417BQ35840376-07A2F322-59BA-4E7A-B3F4-DB6C36473653Q35903351-6A4CDCA0-E51D-4632-9406-A591D0B99C7CQ35924447-0F4478D8-3F0C-4D72-8DA8-D66880F9C5BF
P2860
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@ast
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@en
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@nl
type
label
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@ast
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@en
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@nl
prefLabel
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@ast
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@en
The alpha-synucleinopathies: P ...... , and multiple system atrophy.
@nl
P1476
The alpha-synucleinopathies: P ...... s, and multiple system atrophy
@en
P2093
M G Spillantini
P356
10.1111/J.1749-6632.2000.TB06900.X
P407
P577
2000-01-01T00:00:00Z